2019
DOI: 10.1021/acs.biomac.9b00868
|View full text |Cite
|
Sign up to set email alerts
|

HPMA-Based Nanoparticles for Fast, Bioorthogonal iEDDA Ligation

Abstract: Fast and bioorthogonally reacting nanoparticles are attractive tools for biomedical applications such as tumor pretargeting. In this study, we designed an amphiphilic block copolymer system based on HPMA using different strategies to introduce the highly reactive click units 1,2,4,5-tetrazines (Tz) either at the chain end (Tz-CTA) or statistical into the hydrophobic block. This reactive group undergoes a rapid, bioorthogonal inverse electron-demand Diels–Alder reaction (iEDDA) with trans-cyclooctenes (TCO). Su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2019
2019
2025
2025

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 57 publications
0
15
0
Order By: Relevance
“…All nanoparticles (30 mg mL −1 ) were incubated with EDTA‐stabilized, pure and undiluted plasma 1:1 (v:v) at 37 °C for 1 h. The concentration of nanoparticles during plasma incubation was thus higher than during possible in vivo scenario, for which they were calculated to be 0.133 mg mL −1 the in the blood pool. [ 66 ] For a sufficient separation, the AF4 was limited to a maximal plasma concentration of 5 vol%. Therefore, after incubation the samples had to be diluted with PBS to a particle concentration of 1.5 g L −1 and a 5 vol% solution of plasma and immediately measured in AF4.…”
Section: Methodsmentioning
confidence: 99%
“…All nanoparticles (30 mg mL −1 ) were incubated with EDTA‐stabilized, pure and undiluted plasma 1:1 (v:v) at 37 °C for 1 h. The concentration of nanoparticles during plasma incubation was thus higher than during possible in vivo scenario, for which they were calculated to be 0.133 mg mL −1 the in the blood pool. [ 66 ] For a sufficient separation, the AF4 was limited to a maximal plasma concentration of 5 vol%. Therefore, after incubation the samples had to be diluted with PBS to a particle concentration of 1.5 g L −1 and a 5 vol% solution of plasma and immediately measured in AF4.…”
Section: Methodsmentioning
confidence: 99%
“…Utilizing a similar strategy, Kramer et al used the iEDDA method for the synthesis of fast and bioorthogonally reacting nanoparticles to pretarget tumor cells ( Figure a). [ 179 ] Micelles were prepared from amphiphilic block copolymers based on N ‐(2‐hydroxypropyl)methacrylamide (HPMA) and then core‐crosslinked to yield micelle nanoparticles by UV light (Figure 6b). These micelle nanoparticles were subsequently modified with methylated Tz moieties, which were stable in blood plasma.…”
Section: Strategies For Antibody Functionalizationmentioning
confidence: 99%
“…a,b) Reproduced with permission. [ 179 ] Copyright 2019, American Chemical Society. c) Schematic illustration and TEM image of the drug‐loaded MSNs‐Tz consisting of MSN (gray circle), chemotherapeutic agent (DOX; not shown), and tetrazine (Tz) at the terminal end of the long‐chain PEG.…”
Section: Strategies For Antibody Functionalizationmentioning
confidence: 99%
See 1 more Smart Citation
“…As mention earlier, the TCO/Tz cycloaddition using mAbs-conjugates prevails in the scientific literature, but this strategy could also be applied to other systems such as organic molecules, peptides, mAbs fragments, nanoparticles, or polymeric micelles . On one hand, using smaller structures than mAbs as vectors for TCOs, such as peptides, chemistries, or mAbs fragments, could further increase the therapeutic index by concentrating higher doses of Tz-ligands in tumors.…”
Section: Iedda Improvements and Prospects For Clinical Applicationsmentioning
confidence: 99%